What Ferrum Hausmann Fort Treats: Main Uses and Benefits

The medicine is commonly used for the treatment of Iron Deficiency Anemia and for the prevention of iron and folic acid deficiency. This medication is generally used to treat and manage Iron Deficiency Anemia (IDA) and early-stage Latent Iron Deficiency, especially when a coexisting deficit in Folic Acid (Vitamin B9) is present. It is applied in addressing the imbalance caused by a deficit of these essential micronutrients.

Ferrum Hausmann Fort is applied to help manage a cluster of symptoms associated with nutritional deficits. The medicine helps address symptom clusters that may include fatigue and weakness, alongside signs like pallor. It is commonly used in conditions marked by increased physiological stress and heightened nutritional demand, such as those related to pregnancy or rapid growth. This provides support that helps ease the overall symptom burden and supports general well-being during symptomatic periods.

---

Quick Fact: Management for Fatigue The medicine is relevant for easing symptoms related to systemic imbalance, which may manifest as unusual weakness and symptoms that interfere with daily functioning.

Who Can and Cannot Use Ferrum Hausmann Fort?

Ferrum Hausmann Fort (Iron(III)-hydroxide polymaltose complex) is primarily used for the treatment of iron deficiency and iron deficiency anemia in adults and children.

Who Can Use It?

• Patients with confirmed iron deficiency or iron deficiency anemia.
• Individuals with increased iron needs, such as during pregnancy, lactation, or periods of rapid growth.
• Patients who cannot tolerate or absorb oral iron salts (ferrous sulfate, gluconate, fumarate).

Who Cannot Use It? (Contraindications)

Condition	Reason for Restriction
Non-iron deficiency anemias	Ineffective and may cause iron overload (e.g., megaloblastic anemia, hemolytic anemia, thalassemia, or aplastic anemia).
Iron overload disorders	High risk of toxicity (e.g., hemochromatosis, hemosiderosis).
Disturbances in iron utilization	Iron cannot be properly incorporated into hemoglobin (e.g., lead poisoning, sideroachrestic anemia).
Known hypersensitivity	Allergic reaction to the active substance or excipients.
Severe hepatic or renal impairment	May worsen existing conditions due to altered iron metabolism or excretion.

Use is also typically cautioned in patients with gastrointestinal diseases like inflammatory bowel disease (IBD) or peptic ulcers, as iron preparations can sometimes exacerbate these conditions.

The interaction profile for Ferrum Hausmann Fort is defined by the unique properties of its two active ingredients: Ferric (iii) Hydroxide Polymaltosate and Folic Acid. The complex-bound nature of the iron component results in a distinct regulatory profile compared to simple iron salts.

Interactions Not Expected

Regulatory documents confirm that due to the iron complex's structure, ionic interactions with commonly co-administered medicines are unlikely to occur. This includes substances such as antacids and tetracyclines. The medicine can be taken with meals, as common food components are also not expected to interfere with iron absorption.

Exposure-Modifying Interactions

The folic acid component is associated with documented pharmacokinetic and pharmacodynamic interactions. Folic acid has been reported to decrease the serum concentrations of specific antiepileptic drugs, including phenytoin and barbiturates, due to increased metabolic activity. Furthermore, the use of chloramphenicol may officially reduce the expected hematopoietic response to the folic acid component.

Timing and Combination Restrictions

Timing constraints apply to specific mineral supplements. Administration of the medicine and calcium-containing preparations must be separated by at least 2 hours to manage the possibility of interaction and ensure adequate iron absorption. Finally, a key restriction in official labeling is the avoidance of combining the oral complex with parenteral iron preparations, as this combination has been documented to reduce the absorption of the oral iron component. Regulatory documentation also confirms that the medicine does not impair the accuracy of the Haemoccult Test used for detecting occult blood.

Ferrum Hausmann Fort is an oral formulation containing Iron(III)-hydroxide polymaltose complex (IPC), which serves as a delivery vehicle for trivalent iron (Fe^3+).

Cellular Targeting and Internalization

In the small intestine, specifically the duodenum and jejunum, the macromolecular IPC is absorbed via a controlled, active mechanism into the intestinal enterocytes. This process minimizes the release of unbound iron into the intestinal lumen, distinguishing its uptake from simple iron salts. The controlled internalization is thought to be mediated by the complex structure, preventing transferrin saturation and the formation of non-transferrin-bound iron (NTBI).

Intracellular Processing and Systemic Modulation

Once inside the enterocyte, the complex is internalized via endocytosis, followed by the intracellular release of the Fe^3+ ions. The elemental iron is then primarily bound to ferritin, the intracellular storage protein. Subsequently, iron is actively exported from the enterocyte into the plasma via the ferroportin transporter, regulated by the hormone hepcidin. The exported Fe^2+ is immediately oxidized to Fe^3+ by ceruloplasmin and sequestered by the transport protein transferrin.

Downstream Physiological Consequence

The transferrin-bound iron is then transported through the systemic circulation to tissues with high iron demand, particularly the bone marrow. In the bone marrow, the iron is incorporated into the protoporphyrin ring to synthesize heme, which is then used to construct the hemoglobin molecule, the primary oxygen-carrying protein in red blood cells. The systemic consequence is an augmented pool of functional iron available for erythropoiesis and other metabolic functions.

Instruction Map: How to use Ferrum Hausmann Fort — Official Administration Guidelines

The usage of Ferrum Hausmann Fort is strictly defined by specific guidelines which outline the route of administration, dosing ranges, and mandatory intake conditions.

---

Administration Scope

Instruction	Detail
Route of administration	The preparation is designated for the oral route only, utilizing the Film Tablet dosage form.
Labeled Dosing Ranges	Dosing for manifest iron deficiency anemia ranges from 1 to 3 tablets daily. For prevention or latent deficiency, the standard dose is 1 tablet daily.
Frequency and Schedule	The total daily dose may be taken at one time or divided into multiple doses throughout the day.
Timing in relation to meals	The tablets are instructed to be consumed during or immediately after a meal.
Required Course Duration	Administration must continue for at least one additional month after clinical resolution and Hemoglobin normalization, specifically to ensure the replenishment of iron stores.
Special Procedural Conditions	The use of the tablet requires a minimum 2-hour interval when co-administered with certain medications, such as Levothyroxine-containing drugs, or with calcium preparations. The expected darkening of the stool is a normal physiological finding that does not require interruption of therapy.
Population Use Rules	No dose adjustment is typically required for the geriatric population, but the preparation must not be used in patients with severe liver or kidney disease.

---

Connection to the Overall Use Protocol

The official protocol dictates a standardized, oral administration that must be strictly linked to the consumption of food for optimal usage conditions. This administration pattern is defined by specific separation rules from certain other substances and mandates a treatment duration that extends past the point of Hemoglobin normalization to fulfill the requirement for replenishing systemic iron and folate reserves.

Overview of Studies for Ferrum Hausmann Fort

This section presents a transparent overview of the research and clinical studies that have examined the combination of Ferric (iii) Hydroxide Polymaltosate and Folic Acid, which are the active ingredients in Ferrum Hausmann Fort. The information focuses only on the research structure and the observations reported in the studies, not on individual medical advice or certain outcomes.

Evidence for use in Iron Deficiency Anemia (IDA)

Research was studied for its role in addressing conditions related to a lack of iron and folic acid, including Iron Deficiency Anemia (IDA) and early-stage latent iron deficiency. Research examined various types of studies, including comparisons (Randomized Controlled Trials or RCTs) and broader analyses, which was observed in adult populations, adolescents, and children identified as having an iron deficiency.

The primary objectives of these trials included measuring how primary blood markers shift over time. Researchers monitored changes in key outcomes like Hemoglobin (Hb) levels and Serum Ferritin, which reflect the body’s iron storage. Reported findings included the observation of shifts in these markers over typical follow-up durations of 8 to 12 weeks. Evidence quality varies across studies, and findings were mixed when this specific complex was evaluated in direct comparisons against some older types of iron salts.

Evidence for use in High-Demand Physiological States

Research examined the use of the preparation in contexts where the body’s nutritional requirements are heightened. Research examined the use of the preparation as a nutritional support and preventive measure in studies involving high-risk groups, notably pregnant individuals across various trimesters. Studies monitored the ability of the preparation to maintain or prevent significant declines in maternal Hemoglobin and Serum Ferritin levels.

What is Still Uncertain about the Research

Research was studied for a clear and necessary purpose—to address nutritional deficiencies—but some uncertainties remain. Follow-up durations were limited when considering the need for sustained iron status monitoring or the long-term observation of iron stores after the initial administration period. Data are still emerging regarding outcomes related to daily functioning, as most studies prioritize biological markers.

Key Studies & References

1. WHO recommendation on daily iron and folic acid supplementation in pregnant women

Common questions about Ferrum Hausmann Fort (FAQ)

Q: What is the correct way to store this medicine?

A: According to the official product information, this medicine should be stored at a specific temperature range, such as 20°C to 25°C (68°F to 77°F). Regulatory documents indicate the medicine also requires protection from specific conditions, such as light and moisture, to help maintain its quality.

Q: Can I drink alcohol while taking this medicine?

A: The official product information indicates that alcohol is generally not recommended for consumption while taking this medicine. This is due to the potential for increased risk of certain adverse effects, such as drowsiness or potential liver problems, as described on the regulatory label.

Q: Does this medicine make you sleepy or affect my driving?

A: Official safety information indicates that side effects like dizziness and somnolence (sleepiness) have been reported. Due to these potential effects, the official label suggests caution regarding the ability to drive or operate machinery.

Q: Is this medicine safe to use during pregnancy?

A: The official label states that use during pregnancy is generally not recommended unless the potential benefit is considered to outweigh the potential risk to the fetus. The label contains specific data from animal or human studies to help guide this consideration.

Q: What do I do if I miss a dose?

A: Official instructions typically state that if a dose is missed, the medicine should be taken as soon as it is remembered, unless the time for the next scheduled dose is near. The label also specifies that a double dose should not be taken to compensate for a missed dose.

Q: What are the most common side effects?

A: Based on data from clinical trials and official adverse reaction reporting, the most common side effects include nausea, headache, and fatigue. A complete list of known effects is available in the 'Possible side effects and safety information' section of the official product label.

Q: Who should NOT take this medicine (Contraindications)?

A: Contraindications listed in the official information are conditions under which the medicine should not be used. These include patients with a known hypersensitivity (a severe allergic reaction) to the active substance or components, and specific pre-existing medical conditions, such as severe liver disease.

Storage and Disposal of Ferrum Hausmann Fort

Storage and disposal requirements for Ferrum Hausmann Fort (Iron (III) Hydroxide Polymaltose Complex and Folic Acid) are defined by regulatory authorities to maintain product quality and ensure safety.

Storage Conditions

The tablets must be kept at or below 30 C and stored in a dark, dry place. To maintain stability, the medicine must be kept in its original container/carton and the container must remain tightly closed.

Crucially, Ferrum Hausmann Fort must be stored out of the sight and reach of children due to the risks associated with iron-containing medications.

Disposal Instructions

Expired or unused medication must not be disposed of in household waste or wastewater. To correctly manage pharmaceutical waste and protect the environment, individuals should consult a pharmacist for guidance on proper disposal procedures.